溶栓
尿激酶
体内
纤溶酶原激活剂
乙二醇
化学
尿激酶受体
壳聚糖
激活剂(遗传学)
超声
重组组织纤溶酶原激活剂
超声波
生物医学工程
生物物理学
药理学
医学
缺血
外科
生物化学
内科学
色谱法
生物
放射科
受体
有机化学
缺血性中风
改良兰金量表
心肌梗塞
生物技术
作者
Haiqiang Jin,Hui Tan,Lingling Zhao,Weiping Sun,Lijun Zhu,Yongan Sun,Hong-Jun Hao,Haiying Xing,Linlin Liu,Xiaozhong Qu,Yining Huang,Zhenzhong Yang
标识
DOI:10.1016/j.ijpharm.2012.06.001
摘要
To find a way to modulate the effect of thrombolytic proteins by increasing their specificity, minimizing their adverse effect as well as lengthening their circulation time for the treatment of ischemic vascular disease holds great promise. In this work, urokinase-type plasminogen activator (uPA) was encapsulated into hollow nanogels which are generated by the reaction of glycol chitosan and aldehyde capped poly(ethylene glycol) (OHC-PEG-CHO) through a one-step approach of ultrasonic spray. The uPA-loaded nanogels, with size of 200–300 nm, have longer circulation time than that of the nude urokinase in vivo, besides the protein can be triggered to release in faster rate under diagnostic ultrasonic condition of 2 MHz, which significantly enhanced the thrombolysis of clots. The results are promising for increasing the specificity and positive effects of thrombolytic agents like recombinant tissue plasminogen activator (rt-PA) for the current treatment of ischemic vascular disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI